Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria (2020)

First Author: Kiga K

Attributed to: Translational Research Initiative funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-16731-6

PubMed Identifier: 32523110

Publication URI: http://europepmc.org/abstract/MED/32523110

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1

ISSN: 2041-1723